Showing results (21-30 of 149) with videos related to

Sort By:
Pageof 15
Haematologica|January 22, 2026
Optimal management of elderly/old Ph+ acute lymphoblastic leukemia patientsRobin Foà, Sabina Chiaretti, Felicetto Ferrara, et al.
Hematological Oncology|December 8, 2010
Continuous sequential infusion of fludarabine and cytarabine for elderly patients with acute myeloid leukaemia secondary to a previously diagnosed myelodysplastic syndromeFelicetto Ferrara, Salvatore Palmieri, Tiziana Izzo, et al.
Frontiers in Oncology|November 17, 2025
Unmet needs in patients with acute myeloid leukemia ineligible for intensive approaches: perspectives from a European expert panelFelicetto Ferrara, Klaus Geissler, Priyanka Mehta, et al.
Cancers|February 17, 2019
Current Therapeutic Results and Treatment Options for Older Patients with Relapsed Acute Myeloid LeukemiaFelicetto Ferrara, Federica Lessi, Orsola Vitagliano, et al.
BMC Health Services Research|January 15, 2023
Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in ItalyRoberto Cairoli, Gianluca Furneri, Roberto Di Virgilio, et al.
Frontiers in Oncology|March 7, 2022
Diagnostic Workup of Acute Myeloid Leukemia: What Is Really Necessary? An Italian SurveyMaria Teresa Voso, Felicetto Ferrara, Sara Galimberti, et al.
American Journal of Hematology|July 24, 2010
Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic resultsFelicetto Ferrara, Tiziana Izzo, Clelia Criscuolo, et al.
Haematologica|May 12, 2004
Prolonged molecular remission after autologous stem cell transplantation in relapsed acute promyelocytic leukemiaFelicetto Ferrara, Salvatore Palmieri, Mario Annunziata, et al.
Anticancer Research|April 16, 2010
Acute promyelocytic leukemia in patients aged over 60 years: multicenter experience of 34 consecutive unselected patientsFelicetto Ferrara, Olimpia Finizio, Alfonso D'Arco, et al.
BMC Cancer|October 3, 2020
National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?Federico Lussana, Paola Minetto, Felicetto Ferrara, et al.
Pageof 15